As filed with the Securities and Exchange Commission on March 19, 2024
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
Under
The Securities Act of 1933
SCHOLAR ROCK HOLDING CORPORATION
(Exact name of registrant as specified in its charter)
Delaware | 82-3750435 |
(State or other jurisdiction of | (I.R.S. Employer |
301 Binney Street, 3rd Floor
Cambridge, MA 02142
(857) 259-3860
(Address of Principal Executive Offices)
Scholar Rock Holding Corporation 2018 Stock Option and Incentive Plan
Scholar Rock Holding Corporation 2018 Employee Stock Purchase Plan
Scholar Rock Holding Corporation 2022 Inducement Equity Plan
(Full Title of the Plans)
Jay T. Backstrom
President and Chief Executive Officer
301 Binney Street, 3rd Floor
Cambridge, MA 02142
(857) 259-3860
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copy to:
Junlin Ho
Scholar Rock Holding Corporation
301 Binney Street, 3rd Floor
Cambridge, MA 02142
(857) 259-3860
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ | Accelerated filer ☐ |
Non-accelerated filer ☒ | Smaller reporting company ☒ |
| |
Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed by Scholar Rock Holding Corporation (the “Registrant”) to register 3,039,179 additional shares of common stock, par value $0.001 per share, reserved for issuance under the Scholar Rock Holding Corporation 2018 Stock Option and Incentive Plan, 353,614 additional shares of common stock, par value $0.001 per share, reserved for issuance under the Scholar Rock Holding Corporation 2018 Employee Stock Purchase Plan and 1,000,000 additional shares of common stock, par value $0.001 per share, reserved and available for issuance under the Scholar Rock Holding Corporation 2022 Inducement Equity Plan.
Pursuant to General Instruction E of Form S-8 regarding Registration of Additional Securities, the contents of the Registration Statements filed on Form S-8 (File No. 333-225192, File No. 333-238082, File No. 333-256065, File No. 333-263349, File No. 333-266658, File No. 333-268327 and File No. 333-270318) filed with the Securities and Exchange Commission on May 24, 2018, May 7, 2020, May 13, 2021 and March 7, 2022, August 8, 2022, November 14, 2022 and March 7, 2023, respectively, are hereby incorporated by reference in this Registration Statement to the extent not replaced hereby.
Part II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
Exhibit No. | Description |
3.1 | |
3.2 | |
5.1* | |
23.1* | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm. |
23.2* | |
24.1* | Power of Attorney (included on signature page). |
99.1 | |
99.2 | |
99.3 | |
99.4 | |
99.5 | |
99.6 | |
107* |
* | Filed herewith. |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cambridge, Commonwealth of Massachusetts, on the 19th day of March, 2024.
SCHOLAR ROCK HOLDING CORPORATION | |
By: /s/ Jay T. Backstrom | |
Jay T. Backstrom | |
President and Chief Executive Officer (Principal Executive Officer) |
POWER OF ATTORNEY AND SIGNATURES
KNOW ALL BY THESE PRESENT, that each individual whose signature appears below hereby constitutes and appoints each of Jay T. Backstrom and Edward H. Myles as such person’s true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such person’s name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following person in the capacities and on the date indicated.
Signature | Title | Date |
/s/ Jay T. Backstrom | President and Chief Executive Officer (Principal Executive Officer) | March 19, 2024 |
Jay T. Backstrom | ||
/s/ Edward H. Myles | Chief Operating Officer and Chief Financial Officer (Principal Financial and Accounting Officer) | March 19, 2024 |
Edward H. Myles | ||
/s/ David Hallal | Chairman of the Board of Directors | March 19, 2024 |
David Hallal | ||
/s/ Srinivas Akkaraju | Director | March 19, 2024 |
Srinivas Akkaraju, M.D., Ph.D. | | |
/s/ Richard Brudnick | Director | March 19, 2024 |
Richard Brudnick | | |
/s/ Kristina Burow | Director | March 19, 2024 |
Kristina Burow | ||
/s/ Jeffrey S. Flier | Director | March 19, 2024 |
Jeffrey S. Flier, M.D. | ||
/s/ Michael Gilman | Director | March 19, 2024 |
Michael Gilman, Ph.D. | ||
/s/ Amir Nashat | Director | March 19, 2024 |
Amir Nashat, Sc.D. | ||
/s/ Katie Peng | Director | March 19, 2024 |
Katie Peng | | |
/s/ Joshua Reed | Director | March 19, 2024 |
Joshua Reed | ||
/s/ Akshay Vaishnaw | Director | March 19, 2024 |
Akshay Vaishnaw, M.D., Ph.D. |